Moffitt Cancer Center | Strategic Alliance Partners

Latest from Moffitt Cancer Center

Chief Pharmacy Officer of Moffitt Cancer Center Discusses NCCN Biosimilar Recommendations

April 30, 2021

Video

Kenneth Komorny, PharmD, BCPS, a co-lead on development of National Comprehensive Cancer Network recommendations for biosimilar management, explains some of the positions the NCCN has taken.

Pharmacy Times ® Adds Five Notable New Partners to its Strategic Alliance Partnership Program

April 05, 2021

Article

These nationally recognized health system and oncology leaders will join the esteemed SAP Program.

Obtaining Real-World Disease, Demographic Data on Myelofibrosis

December 11, 2020

Article

Rami Komrokji, MD, clinical director of malignant hematology and department lead clinical investigator at the H. Lee Moffitt Cancer Center and Research Institute speaks about why data are limited in myelofibrosis.

Making Treatment Decisions for Patients with Myelofibrosis

December 10, 2020

Video

Rami Komrokji, MD, clinical director of malignant hematology and department lead clinical investigator at the H. Lee Moffitt Cancer Center and Research Institute speaks about factors in treatment decisions for patients with myelofibrosis.

Triple-Negative Breast Cancer: Improved Outcomes and Providing Patient-Centered Care

March 03, 2020

Article

Melissa B. Armitage, PharmD, BCOP, a clinical pharmacist who works in breast oncology at the Moffitt Cancer Center in Tampa, Florida, discussed this disease's pathophysiology, natural progression, and risk factors.